China Universal Asset Management Co., Ltd. Ab Cellera Biologics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q2 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 59,949 shares of ABCL stock, worth $353,699. This represents 0.02% of its overall portfolio holdings.
Number of Shares
59,949
Previous 59,771
0.3%
Holding current value
$353,699
Previous $133,000
54.14%
% of portfolio
0.02%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding ABCL
# of Institutions
149Shares Held
115MCall Options Held
488KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY27.5MShares$162 Million0.96% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$78.8 Million0.01% of portfolio
-
Baillie Gifford & CO10.4MShares$61.1 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL8.47MShares$50 Million0.01% of portfolio
-
Credit Suisse Ag Zurich, V84.55MShares$26.8 Million0.02% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.68B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...